SAB Biotherapeutics to Present at 2022 H.C. Wainwright Global Investment Conference
SAB Biotherapeutics, Inc. (SABS)
Company Research
Source: GlobeNewswire
SIOUX FALLS, S.D., May 12, 2022 (GLOBE NEWSWIRE) -- SAB Biotherapeutics (NASDAQ: SABS), announced today its participation at the H.C. Wainwright Global Investment Conference, which takes place May 23-26, 2022. As part of the conference, the company’s management team will participate in a live Fireside Chat on Wednesday, May 25, 2022 at 9:00 am EDT / 8:00 am CDT. An on-demand webcast of the presentation will be accessible under “News & Events” in the Investors section of the company’s website at www.sabbiotherapeutics.com. A replay of the webcast will be available on the SAB website for 90 days following the presentation. H.C. Wainwright hosted events are intended for prospective and existing H.C. Wainwright clients only. To request a one-on-one meeting with management or to participate at the live event, please contact your H.C. Wainwright representative with interest. About SAB Biotherapeutics, Inc.SAB Biotherapeutics, Inc. (SAB) is a clinical-stage, biopharmaceutical company ad
Show less
Read more
Impact Snapshot
Event Time:
SABS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SABS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SABS alerts
High impacting SAB Biotherapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
SABS
News
- SAB Biotherapeutics, Inc. (NASDAQ: SABS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock.MarketBeat
- SAB Biotherapeutics, Inc. (NASDAQ: SABS) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $25.00 price target on the stock.MarketBeat
- SAB Biotherapeutics Provides SAB-142 Trial Update [Yahoo! Finance]Yahoo! Finance
- SAB Biotherapeutics Provides SAB-142 Trial UpdateGlobeNewswire
- SAB Biotherapeutics to Present at INNODIA Annual Meeting [Yahoo! Finance]Yahoo! Finance
SABS
Earnings
- 8/21/23 - Beat
SABS
Sec Filings
- 4/15/24 - Form 8-K
- 3/29/24 - Form 8-K
- 3/29/24 - Form 10-K
- SABS's page on the SEC website